A syllabus for fellowship education in palliative medicine

American Journal of Hospice and Palliative Medicine

Volumn 20, Issue 4, 2003, Pages 279-289

  LeGrand, Susan B ^a   Walsh, Declan ^a   Nelson, Kristine A ^a,b   Davis, Mellar P ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b Cancer Treatment Research Foundation   (United States)

Author keywords

Education; Hospice; Palliative medicine; Training

Indexed keywords

CONSULTATION; EDUCATION PROGRAM; HOSPICE CARE; HUMAN; MEDICAL EDUCATION; MEDICAL SERVICE; MEDICAL SOCIETY; MEDICAL SPECIALIST; OUTPATIENT CARE; PALLIATIVE THERAPY; PATIENT CARE; REVIEW; SKILL; STANDARD; UNITED STATES; ARTICLE; CLINICAL COMPETENCE; CURRICULUM; EDUCATIONAL MODEL; HOSPITAL; INTEGRATED HEALTH CARE SYSTEM; MEDICINE; METHODOLOGY; ORGANIZATION; ORGANIZATION AND MANAGEMENT;

CLINICAL COMPETENCE; CURRICULUM; DELIVERY OF HEALTH CARE, INTEGRATED; EDUCATION, MEDICAL, GRADUATE; FELLOWSHIPS AND SCHOLARSHIPS; HOSPICE CARE; HOSPITALS, GROUP PRACTICE; HUMANS; MODELS, EDUCATIONAL; OHIO; ORGANIZATIONAL INNOVATION; ORGANIZATIONAL OBJECTIVES; PALLIATIVE CARE; SPECIALTIES, MEDICAL; UNITED STATES;

EID: 0141447228     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990910302000410     Document Type: Review

References (87)

1. Billings JA: Palliative medicine fellowship programs in the United States: Year 2000 survey. J Palliat Med. 2000; 3: 391-396.
2. Billings JA, Block SD, Finn JW, et al.: Standards for fellowship training in palliative medicine. J Palliat Med. 2002; 5(1): 23-33.
3. LeGrand S, Walsh D, Nelson K, et al.: Development of a Clinical Fellowship Program in Palliative Medicine. J Pain Symptom Manag. 2000; 20(5): 345-352.
4. Walsh D: Pioneer Programs in Palliative Care: Nine Case Studies. New York: Millbank Memorial Fund, 2000, 51-73.
5. Degner LF, Sloan JA: Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage. 1995; 10(6): 423-431.
6. Hopwood P, Stephens RJ: Symptoms at presentation for treatment in patients with lung cancer: Implications for the evaluation of palliative treatment. Br J Cancer. 1995; 71(3): 633-636.
7. The SUPPORT Principle Investigators: A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognosis and preferences for outcomes and risks of treatment. JAMA. 1995; 274: 1591-1598.
8. Rosenberg EE, Lussier MT, Beaudoin C: Lessons for clinicians from physician-patient communication literature. Arch Fam Med. 1997; 6(3): 279-283.
9. Buckman R: How to Break Bad News - A Guide for Health Care Professionals. London: Macmillan Medical, 1993.
10. Stagno S, Zhukovsky DM, Walsh D: Bioethics: Communication and decision-making in advanced disease. Semin Oncol. 2000; 27(1): 69-84.
11. Miller RD, Krech R, Walsh TD: Role of a palliative care service family conference in the management of advanced cancer. Palliat Med. 1991; 5: 34-42.
12. Nelson KA, Walsh D, Abdullah O, et al.: Common complications of advanced cancer. Semin Oncol. 2000; 27(1): 34-44.
13. Komurcu S, Nelson KA, Walsh D, et al.: Common symptoms in advanced disease. Semin Oncol. 2000; 27(1): 24-33.
14. Donnelly S, Walsh TD: The symptoms of advanced cancer in 1000 patients: Identification of clinical priorities by assessment of prevalence and severity. J Palliat Care. 1995; 11(1): 27-32.
15. Walsh D: Prevalence of symptoms among patients with advanced cancer: An international collaborative study. J Pain Symptom Manage. 1996; 12(1): 3-10.
16. Walsh D, Doona M, Molnar M: Symptom control in advanced cancer: Important drugs and routes of administration. Semin Oncol. 2000; 27(1): 69-83.
17. Walsh D: Pharmacological management of cancer pain. Semin Oncol. 2000; 27(1): 45-63.
18. Steinhauser KE, Christakis NA, Clipp EC, et al.: Factors considered important at the end of life by patients, family, physician, and other care providers. JAMA. 2000; 284: 2476-2482.
19. Miller R, Walsh TD: Psychosocial aspects of palliative care in advanced cancer. J Pain Symptom Manage. 1991; 6(1): 24-29.
20. Nelson K, Walsh D, Behrens C, et al.: The dying cancer patient. Semin Oncol. 2000; 27(1): 84-89.
21. Tropiano P, Zajac D, Walsh D: Organization of services and nursing care: Hospice and palliative medicine. Semin Oncol. 2000; 27(1): 7-13.
22. Davis MP, Walsh D, Nelson K, et al.: The business of palliative medicine: Management metrics for an acute care inpatient unit. Am J Hosp Palliat Care. 2001; 18(1): 26-29.
23. Twycross R, Fallon M, Sharma K, et al.: The effect of treatment choices on the total cost of palliative care. Eur J Palliat Care. 1999; 6(3): 94-97.
24. European Association for Palliative Care: Report and Recommendations of a Workshop on Palliative Medicine Education and Training for Doctors in Europe. Brussels: European Association for Palliative Care, 1993.
25. American College of Graduate Medical Education: Strategic Initiatives Committee minutes, February 14, 2000.
26. Doyle D, Hanks GWC, MacDonald N (eds.): Introduction. Oxford Textbook of Palliative Medicine, Second Ed. Oxford, UK: Oxford Medical Publications, 1998, 3-8.
27. Ahmedzai S, Walsh D: Palliative medicine and modern cancer care. Semin Oncol. 2000; 27(1): 1-6.
28. Randall F, Downie RS: Palliative Care Ethics: A Companion for All Specialties. Oxford, UK: Oxford University Press, 1999.
29. Clive JC, Roberts SW, Hanks G: The principles of drug use in palliative medicine. In Doyle D, Hanks GWC, MacDonald N (eds.): Oxford Textbook of Palliative Medicine, Second Ed. Oxford, UK: Oxford Medical Publications, 1998, 223-238.
30. LeGrand SB: Communication in advanced disease. Curr Oncol Rep. 2000; 2(4): 358-361.
31. Osaba D, MacDonald N: Principles governing the use of cancer chemotherapy in palliative care. In Doyle D, Hanks GWC, MacDonald N (eds.): Oxford Textbook of Palliative Medicine, Second Ed. Oxford, UK: Oxford Medical Publications, 1998, 249-266.
32. Ellison NM: Palliative Chemotherapy: Principles and Practice of Supportive Oncology. New York: Lippincott-Raven Publishers, 1998, 667-680.
33. Hoskin PJ: Radiotherapy in symptom management. In Doyle D, Hanks GWC, MacDonald N (eds.): Oxford Textbook of Palliative Medicine. Oxford, UK: Oxford Medical Publications, 1998, 267-281.
34. Pinover WH, Coia LR: Palliative Radiation Therapy: Principles of Supportive Care in Cancer. New York: Lippincott-Raven Publishers, 1998, 603-636.
35. Komurcu S, Nelson K, Walsh D: The gastrointestinal symptoms of advanced cancer. Support Care Cancer. 2001; 9(1): 32-39.
36. Homsi J, Walsh D, Panta R, et al.: Infectious complications in advanced cancer. Support Care Cancer. 2000, 8(6): 487-492.
37. Sharma S, Walsh TD: Management of symptomatic malignant ascites with diuretics: Two care reports and a review of the literature. J Pain Symptom Manage. 1995; 10(3): 327-342.
38. Markman M: Early recognition of spinal cord compression in cancer patients. Cleve Clin J Med. 1999; 66(10): 629-631.
39. Mundy GR, Cruise TA: Hypercalcemia of malignancy. Am J Med. 1997; 103(2): 134-145.
40. Sorensen JB, Anderson MK, Hansen HH: Syndrome of inappropriate secretion of anti-diuretic hormone (SIADH) in malignant disease. J Intern Med. 1995; 238(2): 97-110.
41. Sarhill N, Walsh D, Nelson K: Hydromorphone: Pharmacology and clinical applications. Support Care Cancer. 2001; 9(2): 84-96.
42. Davis MP, Walsh D: Methadone for relief of cancer pain: A review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer. 2001; 9(2): 73-83.
43. Nelson J, Glare P, Walsh TD: Crossover study of subcutaneous and intravenous morphine given by continuous infusion for chronic severe pain in advanced cancer. J Pain Symptom Manage. 1997; 13(5): 262-267.
44. Smyth E, Walsh TD, Currie K: A pilot study, dosing guidelines, and review of the literature of patient controlled analgesia (PC) using subcutaneous morphine sulfate in the treatment of chronic cancer pain. Palliat Med. 1992; 6: 217-226.
45. Glare PA, Walsh TD: Dose ranging study of oxycodone for chronic pain in advanced cancer. J Clin Oncol. 1993; 5(11): 973-978.
46. Glare PA, Walsh TD: Clinical pharmacokinetics of morphine. Ther Drug Monit. 1991; 13(1): 1-23.
47. Doyle D, Hanks GWC, MacDonald N (eds.): Oxford Textbook of Palliative Medicine, Second Ed. Oxford, UK: Oxford Medical Publications, 1998, 203-222.
48. Homsi J, Walsh D, Nelson K: Psychostimulants in supportive care. Support Care Cancer. 2000; 8(5): 385-397.
49. Homsi J, Nelson K, Walsh D: Hydrocodone for cough in advanced cancer. Am J Hosp Palliat Care. 2000; 17(5): 342-346.
50. Homsi J, Nelson K, Walsh D: Methylphenidate for depression: Case series. Am J Hosp Palliat Care. 2000; 17(6): 393-398.
51. Avashia J, Walsh TD: Glucorticoids in clinical oncology. Cleve Clin J Med. 1992; 59(5): 505-515.
52. Ingham J, Portenoy RK: The measurement of pain and other symptoms. In Doyle D, Hanks GWC, MacDonald N (eds.): Oxford Textbook of Palliative Medicine, Second Ed. Oxford, UK: Oxford Medical Publications, 1998.
53. Komurcu S, Nelson K, Walsh D: The gastrointestinal symptoms of advanced cancer. Support Care Cancer. 2001; 9(1): 32-39.
54. Davis M, Walsh D: Treatment of nausea and vomiting in advanced cancer. Support Care Cancer. 2000; 8(6): 444-452.
55. LeGrand S, Walsh D: Palliative management of dyspnea in advanced cancer. Curr Opin Oncol. 1999; 11(4): 250-254.
56. Nelson K, Walsh D, Sheehan FA: The cancer anorexia-cachexia syndrome. J Clin Oncol. 1994; 12(1): 213-225.
57. Nelson K, Walsh T: Management of dyspnea in advanced cancer. Cancer Bull. 1991; 43: 423-426.
58. Nelson KA, Walsh TD, Deeter P, et al.: A phase II study of delta-9 tetrahydrocannbinol for appetite stimulation in cancer associated anorexia. J Palliat Care. 1994; 10(4): 14-18.
59. Twycross R, Bock I, Walsh D: Nausea and vomiting in advanced cancer. Eur J Palliat Care. 1998; 5(2): 39-45.
60. Ottery F, Walsh D, Stawford A: Pharmacologic management of anorexia/cachexia. Semin Oncol (Suppl.). 1998; 25(2): 35-44.
61. Emanuel LL: Advanced directives. In Berger A, Portenoy R, Weissman D (eds.): Principles and Practice of Supportive Oncology. New York: Lippincott-Raven Publishers, 1998.
62. Powazki RD, Palcisco C, Richardson M: Psychosocial care in advanced cancer. Semin Oncol. 2000; 27(1): 101-108.
63. Powazki R, Walsh D: Acute care palliative medicine: Psychosocial assessment of patients and primary caregivers. J Palliat Med. 1999; 13: 367-374.
64. Gallagher LM, Huston MJ, Nelson KA, et al.: Music therapy in palliative medicine. Support Care Cancer. 2001; 9(3): 156-161.
65. Sarhill N, LeGrand S, Islambouli R, et al.: The terminally ill Muslim: Death and dying from the Muslim perspective. Am J Hosp Palliat Care. 2001; 18(4): 251-255.
66. Spech P: Spiritual issues in palliative care. In Doyle D, Hanks GWC, MacDonald N (eds.): Oxford Textbook of Palliative Medicine, Second Ed. Oxford, UK: Oxford Medical Publications, 1998, 805-816.
67. Vachon LS, Ferreel BR: Emotional problems in palliative care. In Doyle D, Hanks GWC, MacDonald N (eds.): Oxford Textbook of Palliative Medicine, Second Ed. Oxford, UK: Oxford Medical Publications, 1998, 883-932.
68. McIver B, Walsh TD, Nelson K: The use of chlorpromazine for symptom control in the dying cancer patient. J Pain Symptom Manage. 1994; 9(5): 341-345.
69. Gillick MR: Rethinking the role of tube feeding in patients with advanced dementia. N Engl J Med. 2000; 343(3): 206-210.
70. Brody H, Campbell ML, Farber-Langendoen ML, et al.: Withdrawing intensive life-sustaining treatment - recommendations for compassionate clinical management. N Engl J Med. 1997; 336(9): 652-657.
71. Parkes CM: Bereavement. In Doyle D, Hanks GWC, MacDonald N (eds.): Oxford Textbook of Palliative Medicine, Second Ed. Oxford, UK: Oxford Medical Publications, 1998, 995-1010.
72. Friedman LM, Furberg CD, DeMets DL: Fundamentals of Clinical Trials, Third Ed. New York: Mosby-Yearbook, Inc., 1996.
73. Hulley SB, Cummings SR: Designing Clinical Research - An Epidemiologic Approach. Baltimore: Williams and Wilkins, 1988.
74. Friedman LM, Furberg CD, DeMets DL: Fundamentals of Clinical Trials. New York: Mosby-Yearbook, Inc., 1996.
75. Meinert CL: Clinical Trials - Design, Conduct and Analysis. New York: Oxford University Press, 1986.
76. Pocock SJ: Clinical Trials - A Practical Approach. New York: John Wiley and Sons, 1983.
77. Pak CYC, Adams PM: Techniques of Patient-oriented Research. New York: Raven Press, 1994.
78. Max M, Portenoy R, Laska E: The Design of Analgesic Trials - Advances in Pain Research and Therapy, Volume 18. New York: Raven Press, 1991.
79. Bruera E: Research into symptoms other than pain. In Doyle D, Hanks GWC, MacDonald N (eds.): Oxford Textbook of Palliative Medicine, Second Ed. Oxford, UK: Oxford Medical Publications, 1998, 179-185.
80. Davis BG: Tools for Teaching. San Francisco: Jossey-Bass, 1993.
81. Jennett P, Jones D, Mast T, et al.: Characteristics of self-directed learning. In Davis DA, Fox RD (eds.): Physicians as Learners. Chicago: American Medical Association, 1994, 47-65.
82. Arredondo L: How to Present Like a Pro: Getting People to See Things Your Way. New York: McGraw-Hill Inc., 1991.
83. Slotnick HB: How doctors learn: The role of clinical problems across the medical school-to-practice continuum. Acad Med. 1996; 71(1): 28-34.
84. Slotnick HB: How doctors learn: Physicians' self-directed learning episodes. Acad Med. 1999; 74(10): 1106-1113.
85. Walsh TD, Gombeski WR, Goldstein P, et al.: Managing a palliative oncology program: The role of a business plan. J Pain Symptom Manage. 1994; 9(2): 109-118.
86. Walsh D: Continuing care in the medical center: The Cleveland Clinic Foundation Palliative Care Service. J Pain Symptom Manage. 1990, 5(5): 273-278.
87. Walsh D: The Medicare hospice benefit: A critique from palliative medicine. Palliat Med. 1998; 1(2): 147-149.